Your browser doesn't support javascript.
loading
Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016.
Ross, Joseph S; Rohde, Stefanie; Sangaralingham, Lindsey; Brito, Juan P; Choi, Lauren; Dutcher, Sarah K; Graham, David J; Jenkins, Marjorie R; Lipska, Kasia J; Mendoza, Martin; Qiang, Yandong; Wang, Zhong; Wu, Yute; Yao, Xiaoxi; Shah, Nilay D.
Afiliação
  • Ross JS; Section of General Internal Medicine and the National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut 06510.
  • Rohde S; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut 06510.
  • Sangaralingham L; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut 06510.
  • Brito JP; Yale School of Medicine, New Haven, Connecticut 06510.
  • Choi L; Division of Health Care Policy & Research, Mayo Clinic, Rochester, Minnesota 55905.
  • Dutcher SK; Division of Health Care Policy & Research, Mayo Clinic, Rochester, Minnesota 55905.
  • Graham DJ; Division of Endocrinology, Diabetes, Metabolism, Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.
  • Jenkins MR; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland 20993.
  • Lipska KJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland 20993.
  • Mendoza M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland 20993.
  • Qiang Y; Office of Women's Health, US Food and Drug Administration, White Oak, Maryland 20993.
  • Wang Z; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut 06510.
  • Wu Y; Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut 06510.
  • Yao X; Office of Minority Health, US Food and Drug Administration, White Oak, Maryland 20993.
  • Shah ND; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland 20993.
J Clin Endocrinol Metab ; 104(6): 2305-2314, 2019 06 01.
Article em En | MEDLINE | ID: mdl-30690529

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônios Tireóideos / Medicamentos Genéricos / Medicare Part D Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônios Tireóideos / Medicamentos Genéricos / Medicare Part D Idioma: En Ano de publicação: 2019 Tipo de documento: Article